cells at zeitgeber time (ZT) 15, decreasing it at ZT5 and ZT20 and not changing it at ZT10. LPS also induced a decrease in PER2-IR cells at ZT5, ZT10, and ZT15 but not at ZT20 in the SCN. In the hippocampus, LPS induced a decrease in PER1-IR and PER2-IR cells at both ZTs (ZT10 and ZT15). In the cerebellum, LPS increased the number of PER1-IR cells at ZT10 and decreased it at ZT15, while the number of PER2-IR cells was reduced at both ZTs. Conclusions: These results indicate that a neuroinflammatory condition leads to desynchronization of primary and subordinate brain oscillators, supporting the existence of the integration between the immune and the circadian system.
circadian behavioral rhythms [2] . PER proteins regulate their own transcription by means of a negative feedback loop between them and the nucleus, providing a posttranslational component to the circadian clock mechanism [1] .
The expression of circadian rhythms in physiology and behavior involves the participation of the circadian timing system and includes forebrain structures and the cerebellum [3] , subordinate oscillators which, in normal conditions, can express different patterns of clock genes in close phase or in antiphase with the SCN rhythms [4, 5] .
The ability of pathological conditions to alter clock gene expression in the SCN [6] and peripheral structures [7] [8] [9] is well known, resulting in desynchronization of rhythms such as sleep disorders, daily mood changes, hormone secretion disorders, thermoregulation changes, and locomotor activity phase changes [10, 11] , which in turn can influence the pathological response itself [12] .
Melatonin, a neuroendocrine transducer of photoperiod information and circadian rhythm regulator, decreases after intracerebroventricular injection of the bacterial endotoxin lipopolysaccharide (LPS) [13] . This condition is correlated with the activation of the pineal axis [14] and may represent one of the factors that influence the desynchronization of the clock genes.
Thus, to investigate whether a neuroinflammatory condition could change PER1 and PER2 protein expression in the primary and subordinate brain oscillators, in the present study, PER1 and PER2 protein expression levels were evaluated in the SCN, hippocampus, and cerebellum in a model of neuroinflammation induced by intracerebroventricular LPS injection. Although systemic doses of LPS may act on the clock [6] , this effect is associated with its peripheral actions [7] [8] [9] 15] . Furthermore, in models of intraperitoneal injections, the blood-brain barrier is relatively resistant to LPS, leaving some regions more vulnerable than others to intraperitoneal injections [16] . To investigate the central effects of LPS in the SCN, hippocampus, and cerebellum in the present study, a neuroinflammatory model using intracerebroventricular injection was used. In addition, the plasmatic melatonin content of these animals was evaluated to verify the effect of LPS on the output rhythm of the SCN. Furthermore, quantification of cell death with the caspase marker was evaluated to demonstrate that the brain areas were affected by LPS since caspase function represents part of the innate immune response to an inflammatory environment [17] .
Materials and Methods
All procedures included in this work comply with the ethical standards of the Guidelines for the Care and Use of Mammals in Neuroscience and Behavioral Research and were approved by the local ethics committee (proc. 001/2015). All efforts were made to minimize the number of animals and their suffering.
Intracerebroventricular LPS Injection
Adult male (P60) Wistar rats (n = 40) obtained from the central facility of São Paulo State University were housed under controlled conditions in a 12-h light:12-h dark cycle with lights on at 7: 00 a.m., considered zeitgeber time 0 (ZT0), with controlled temperature and humidity and water and food (Nuvilab, Nuvital, Brazil) ad libitum.
The animals were subjected to surgery to implant a metal guide cannula (0.8 mm) in the left lateral ventricle [13] . After 7 days, 20 animals received sterile saline (5 µL, i.c.v.) (control group) and 20 received LPS (3 µg/5 µL, i.c.v.) (LPS group) (Sigma Chemical, St. Louis, MO, USA). Because the peak effect of LPS is between 1.5 and 4 h and declines after 8 h [18] and systemic LPS disturbs the per1 rhythm in the SCN after 5 h [6] , in the present study, PER1 and PER2 protein expression levels were evaluated 6 h after LPS. Animals were transcardially perfused (n = 5 per ZT) with saline (200 mL), followed by 300 mL of 4% paraformaldehyde at ZT5, ZT10, ZT15, or ZT20. Red lights were used during intracerebroventricular injection, anesthesia, and blood collection when they occurred during the dark phase. Blood collection was performed by means of cardiac puncture immediately prior to the transcardiac perfusion process.
Tissue Collection
Following the protocol described in Campos et al. [19] , after transcardiac perfusion, the brains were cryoprotected and cryosectioned, and the 30-µm-thick sections were serially stored in 10 different stepwise antifreeze solutions. The coronal sections of one series representing the entire extent of the SCN, hippocampus, and cerebellum were placed in a rostrocaudal order. After this, sections representing the same rostrocaudal levels were processed for each antibody.
Immunohistochemistry
The free-floating brain sections were incubated in PER1 (1: 200, Santa Cruz Bio, UK), PER2 (1: 200, Santa Cruz Bio, UK), and caspase (1: 200, Santa Cruz Bio, UK) primary antibodies for 24 h. After the sections had been rinsed in PBS-TX buffer (0.05 M), they were incubated in normal serum (2%) containing the fluorescent secondary antibody Cy3 (1: 200, Jackson Immuno Research, UK) for 2 h. After this, cell nuclei were stained by 6-diamidino-2-phenylindole (DAPI) (Sigma Chemical), and the sections were analyzed by epifluorescence microscopy. The negative staining controls were performed by omitting the primary caspase antibody and with the addition of the PER1 (E-8) blocking peptide (Santa Cruz Biotechnology, sc-398890 P, TX, USA) and PER2 control/ blocking peptide No. 1 PER2 (1-P) (Alpha Diagnostic International Inc., TX, USA) to the primary incubation solution of PER1 and PER2 antibodies, which blocked PER1 and PER2 staining (Fig. 1) .
Plasma Melatonin Determination
The plasmatic melatonin content was determined using the enzyme-linked immunosorbent assay (ELISA) technique with commercial kits following the manufacturer's instruction (Tecan Trading AG, Switzerland). For this, the plasma for this measurement was collected from the heart (left ventricle) by puncture before the transcardiac perfusion process. The data are expressed as the mean ± SEM of plasma content (pg/mL) and in percentages of LPS group in relation to control, n = 3 per group.
Data Analysis
Each coronal section was analyzed under a light field and epifluorescence (Olympus BX50 microscope), and the images were acquired with cellSens software (USA). All visible cells immunoreactive (IR) for each antibody were counted in a series of brain sections (n = 6 sections per brain region, representing rostrocaudal levels of the SCN, hippocampus, and cerebellum) using ImageJ software (McMaster Biophotonics Facility, Canada). The data are expressed as the mean ± standard error of the mean of the PER1-and PER2-IR cell number counted per section in each ZT. The presence of caspase-IR cell bodies was individually evaluated through semiquantitative analysis among the positively labeled regions according to a previously defined rating scale in which + means low optical density; ++ means moderate, and +++ means high optical density.
The SCN sections of ZTs 5, 10, 15 and 20 and the cerebellum and hippocampus sections of ZTs 10 and 15 were analyzed. The analysis of variance followed by Newman-Keuls posttest was applied to compare among ZTs and groups.
Results
The PER1 and PER2 proteins presented variations in day/night expression patterns in the SCN, hippocampus, and cerebellum of the control rats. The hippocampus showed PER1 day/night variation in phase with the SCN unlike the cerebellum, which showed PER1 day/night variation in antiphase with the SCN. In contrast, the hip- pocampus did not show PER2 day/night variation, and the cerebellum showed PER2 day/night variation in phase with the SCN. In the SCN, immunofluorescence analysis of PER1 and PER2 revealed different organizations of both proteins inside this nucleus depending on the ZT. When immunoreactivity was compared across ZTs, few PER1-IR cells were observed throughout the SCN in the LPS group at ZT5 (Fig. 2b) and ZT20 (Fig. 2k) . At ZT10, PER1 was observed throughout the entire SCN both in the control and LPS groups (Fig. 2e, f) . At ZT15, there were fewer PER1-IR cells in the control group than at ZT10 (ZT10 68.0 ± 3.0, ZT15 52.6 ± 7.1, p < 0.001) (Fig. 2h, i, m) . At ZT20, there were more PER1-IR cells in the control group (ZT15 52.6 ± 7.1, ZT20 67.8 ± 3.7, p < 0.001) and fewer in the LPS group (21.0 ± 5.2, p < 0.001) than at ZT15 (Fig. 2k-m) . When PER1 immunoreactivity was compared between the LPS and control groups, LPS increased PER1 expression at ZT15 (control 52.6 ± 7.1, LPS 76.3 ± 4.4, p < 0.001), did not change it at ZT10, and decreased it at ZT5 (control 51.8 ± 11.2, LPS 7.3 ± 3.2, p < 0.001) and ZT20 (control 67.8 ± 3.7, LPS 21.0 ± 5.2, p < 0.001) (Fig. 2m) . PER2 was mainly found in the dorsal part of the SCN at ZT15 and ZT20 in the control group (Fig. 3i, l) . After LPS, the number of PER2-IR cells decreased at ZT5 (control 58.1 ± 5.9, LPS 17.2 ± 3.1, p < 0.001), ZT10 (control 61.0 ± 6.0, LPS 4.5 ± 1.4, p < 0.001), and ZT15 (control 81.0 ± 2.6, LPS 15.1 ± 4.9, p < 0.001) but not at ZT20 (Fig. 3m) .
Besides the effects of LPS in the SCN, the analysis of the melatonin level showed a reduction in nocturnal plasmatic melatonin following LPS (p < 0.05), which suggests a desynchronization of this circadian rhythm (Fig. 4) .
In the hippocampus, the control group showed a low density of PER1-IR and PER2-IR cells in the granular layer and strong staining for both proteins in the polymorphic layer (Fig. 5c, f, i, l) . The LPS changed this pattern by increasing PER1-IR in the granular layer at ZT15 (Fig. 5e ), although this change was not reflected in an increase in the total number of PER1-IR cells (Fig. 5e) . LPS decreased PER1 expression at ZT10 (control 66.2 ± 3.9, LPS 43.3 ± 6.4, p < 0.001) and ZT15 (control 60.0 ± 4.9, LPS 24.0 ± 4.6, p < 0.001) (Fig. 5m) . LPS also decreased the number of PER2-IR cells at ZT10 (control 56.6 ± 4.5, LPS 22.3 ± 2.5, p < 0.001) and ZT15 (control 55.5 ± 3.9, LPS 39.7 ± 3.7, p < 0.001) (Fig. 5n) . The number of caspase-IR cells was increased in the polymorphic layer and granular layer of the dentate gyrus after LPS to a greater extent at ZT10 (Fig. 6a ) than at ZT15 (Fig. 6c, Table 1 ). In the cerebellum, PER1 and PER2 were found in the Purkinje cell layer with peak expression at ZT15 in the control group (Fig. 7f, l-n) . LPS increased PER1 expression at ZT10 (control 13.2 ± 3.5, LPS 21.7 ± 3.4, p < 0.001) and decreased it at ZT15 (control 30.3 ± 4.2, LPS 27.2 ± 4.2, p < 0.05) (Fig. 5a-f, m) . In contrast, LPS decreased PER2 expression at both ZTs (ZT10, control 13.8 ± 3.7, LPS 1.3 ± 1.5, p < 0.001; ZT15, control 30.7 ± 3.2, LPS 20.7 ± 3.5, p < (Fig. 7g-l, n) . Caspase-positive cells were observed in Purkinje cells after LPS at ZT10 and ZT15 (Fig. 6e, g ). In summary, neuroinflammatory stimulation with LPS (3 μg/5 μL i.c.v., 6 h) induced changes in PER1 and PER2 expression in the SCN, hippocampus, and cerebellum depending on the ZT analyzed (Fig. 8) .
Discussion
In agreement with our previous results [13] , there was a reduction in plasmatic melatonin following intracerebroventricular injection of LPS, indicating the loss of the SCN rhythm and consequently the loss of the endocrine photoperiodic information and the protective action of this molecule [20] .
The neuroinflammation induced by intracerebroventricular LPS in the present study resulted in changes in PER1 and PER2 expression in the SCN, hippocampus, and cerebellum dependent on the time analyzed. Previous studies had already demonstrated that systemic LPS significantly changed per2 expression in the SCN [6] . In the present study, the susceptibility to LPS found in the SCN, hippocampus and cerebellum appeared to be dependent on the time of day in which the stimulus was applied. A day-night rhythm in the susceptibility to lethal doses of LPS has already been demonstrated, and inflammation may directly affect the SCN, as suggested by the LPS-induced phase delays during the subjective night [21] . These time-dependent effects are reflected in several phenomena since LPS administration at the beginning of the active period induces severer responses in temperature and proinflammatory cytokines than LPS given in the rest period [22] . As a matter of fact, the evolution of the acute inflammatory environment occurs rapidly, when LPS induces substantially higher levels of cytokines with peak levels between 1.5 and 4 h, which begins to decline 8 h after administration [18] . Therefore, in the present study, we analyzed melatonin content, caspase, PER1 and PER2 expression 6 h after LPS administration.
The relationships between these mechanisms and clinical conditions are evident in clinical studies that have shown a correlation between the time of day and worsening illness manifestations [23] . In the present study, peak expression of PER1 was found at ZT10 and peak expression of PER2 at ZT15 in the SCN, in agreement with results in the mouse [24] and Lewis rats, where peak expression of PER2 occurred in the early part of the dark phase [5] .
Because the SCN may hierarchically influence the subordinate oscillators [25] in several processes, desynchronization of the SCN in response to a neuroinflammatory stimulus could determine changes in the expression pattern of clock genes in other brain areas. In the present study, the differences in the LPS response pattern among the SCN, hippocampus, and cerebellum indicate a possible independence in this response without a hierarchical control of the central clock in relation to its subordinate oscillators [26] .
In the present study, the neuroinflammatory stimulus resulted in variation in PER1 and PER2 expression in different layers of the hippocampus. Whether this immune system response reflects hippocampal function requires further investigation. Some studies have investigated the relationship between the hippocampus and alterations in proinflammatory cytokines, circadian rhythms and psychiatric disorders such as depression [10, 27] .
The cerebellum showed PER1 and PER2 expression in the Purkinje cells, in agreement with the idea that the cerebellum oscillator possibly resides in these cells [28] . Our results showed that PER1 and PER2 expression can change in the cerebellum in a pathological condition.
Considering that various immune functions are under circadian control [11, 29] , the desynchronization of circadian rhythms leads to altered inflammatory responses [30] . Here, we confirmed that immune factors are able to modulate circadian physiology acting at the principal and subordinate oscillators [31] . These conditions reinforce the idea that the immune and circadian system interact in a bidirectional manner [11, 29] .
Whether the effects of LPS exposure on PER1 and PER2 expression found in the present study, not only in the SCN pacemaker but also in the subordinate oscillators, are transitory and whether therapeutics could be used to reestablish the normal phase relationship remain to be answered and could be important for the prevention and/or treatment of inflammatory diseases.
